Treatment requires a medical assessment, a review of current medicines and appropriate follow-up. Discuss pregnancy, breastfeeding, relevant medical conditions and medication interactions with your clinician before starting.
Compounded medications are not FDA-approved; the FDA does not review their safety, effectiveness or quality before marketing. Approval of an ingredient or a brand-name medication does not establish approval of a compounded combination. Many peptides have limited human safety data, and some raise significant safety concerns.
GLP-1 medicines may cause nausea, vomiting, constipation and other adverse effects; serious risks can include pancreatitis, gallbladder problems and dehydration. Some are contraindicated with a personal or family history of medullary thyroid cancer or MEN2. This is not a complete risk list.
Descriptions are educational, not medical advice. Results vary. No peptide is presented here as a proven treatment for anti-aging, injury healing or cognitive enhancement.
FDA information on compounded substances ↗